Senseonics Holdings, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 9, 2023, at 4:30 p.m. Eastern Time
April 27 2023 - 4:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS) a medical
technology company focused on the development and manufacturing of
long-term, implantable continuous glucose monitoring (CGM) systems
for people with diabetes, today announced that it plans to release
its first quarter 2023 financial results after market close on
Tuesday, May 9, 2023.
Management will hold a conference call to review the Company’s
first quarter 2023 performance starting at 4:30 p.m. (Eastern Time)
on the same day. The conference call will be concurrently webcast.
The link to the webcast will be available on Senseonics Holdings,
Inc. website at www.senseonics.com by navigating to “Investor
Relations,” and then “Events & Publications,” and will be
archived there for future reference. To listen to the conference
call, please dial 1-888-317-6003 (US/Canada) or 1-412-317-6061
(International), passcode 7018265, approximately ten to five
minutes prior to start time.
About Senseonics
Senseonics Holdings, Inc. (“Senseonics”) is a medical technology
company focused on the development and manufacturing of glucose
monitoring products designed to transform lives in the global
diabetes community with differentiated, long-term implantable
glucose management technology. Senseonics' CGM systems, Eversense®,
Eversense® XL and Eversense® E3 include a small sensor inserted
completely under the skin that communicates with a smart
transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230427005554/en/
Senseonics Investor Contact Philip Taylor Gilmartin Group
415-937-5406 investors@senseonics.com
Senseonics (AMEX:SENS)
Historical Stock Chart
From May 2024 to Jun 2024
Senseonics (AMEX:SENS)
Historical Stock Chart
From Jun 2023 to Jun 2024